In one paragraphArticle in bioRxiv : the preprint server for biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from itWhat it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
13 authors.
Francesca SchiaffinoFaculty of Veterinary Medicine, Universidad Peruana Cayetano Heredia, San Martin de Porres, Lima, Peru.ORCID 0000-0002-5796-5116 Katia ManzanaresAsociacion Benefica Prisma, Iquitos, Peru.
Tackeshy PinedoAsociacion Benefica Prisma, Iquitos, Peru.
Alejandra CastroFaculty of Veterinary Medicine, Universidad Peruana Cayetano Heredia, San Martin de Porres, Lima, Peru.
Juana NajarroFaculty of Veterinary Medicine, Universidad Peruana Cayetano Heredia, San Martin de Porres, Lima, Peru.
Kerry K CooperSchool of Animal and Comparative Biomedical Sciences, University of Arizona, Tucson, AZ.ORCID 0000-0003-4541-1324 Evangelos MourkasZoonosis Science Center, Department of Medical Sciences, Uppsala University, Uppsala, Sweden.ORCID 0000-0002-7411-4743 Ben PascoeIneos Oxford Institute for Antimicrobial Research, Department of Biology, University of Oxford, Oxford, United Kingdom.ORCID 0000-0001-6376-5121 Craig T ParkerSchool of Animal and Comparative Biomedical Sciences, University of Arizona, Tucson, AZ.
Margaret N KosekAsociacion Benefica Prisma, Iquitos, Peru.
Funding
Genomic Epidemiology of Campylobacter to Improve Disease Control in Low and Middle Income CountriesR01AI158576 · NIAID · UNIVERSITY OF VIRGINIA · PI KOSEK, MARGARET N · 2021 to 2025
$3.3MEnabling Infectious Disease Research Capacity in the Peruvian AmazonD43TW010913 · FIC · UNIVERSITY OF VIRGINIA · PI Margaret N Kosek, MARIBEL PAREDES OLORTEGUI · 2018 to 2026
$2.8MGenomic Epidemiology of Campylobacter in Poultry to Enable the Effective Control of Human Campylobacteriosis in a Middle Income CountryK43TW012298 · FIC · UNIVERSIDAD PERUANA CAYETANO HEREDIA · PI Francesca Schiaffino · 2022 to 2026
$811kGenomic features of host adaptation of Campylobacter in low-income settingsR21AI163801 · NIAID · UNIVERSITY OF VIRGINIA · PI KOSEK, MARGARET N, PARKER, CRAIG THOMAS · 2022 to 2023
$378kFIC NIH HHS D43 TW010913FIC NIH HHS K43 TW012298NIAID NIH HHS R01 AI158576NIAID NIH HHS R21 AI163801
6 · The paper itselfAbstract
In this study we explored phenotypic resistance using traditional Kirby-Bauer methods in human and animal derived
Indexed as
antibiotic resistanceCampylobactermultidrug resistancephenotype
Identifiers
PMID41726879
PMCPMC12918805
What OpenQuestion holds
Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390